Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Up 0.2%
Mon, 2 Sep 10:11

INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Up 0.2%Image source: DNY59/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 6% and is presently trading at Rs 421.3.

Meanwhile, the BSE HEALTHCARE index is at 43,283.1 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 5.8%) and Pfizer (up 4.4%).

Dr. Reddys (down 1.1%) and Cadila Healthcare (down 1.1%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 182.5 to Rs 421.3, registering a gain of Rs 238.8 (up 130.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,815.8 to 43,283.1, registering a gain of 55.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 135.7%), Glenmark Pharma (up 127.6%) and SUVEN PHARMACEUTICALS (up 125.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,554.4 (up 0.2%).

The top gainers among the BSE Sensex today are ITC (up 2.1%) and Bajaj Finserv (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,299.4 (up 0.3%). Bajaj Finserv and Bajaj Finance are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,075.8 to 82,554.4, registering a gain of 17,478.6 points (up 26.9%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 27.9.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!